The Bioprocessing Excellence in South Asia Award was given during the Asia-Pacific Bioprocessing Excellence Awards (ABEA) 2023, which took place in Singapore earlier this month. The award was given to Biocon Biologics Ltd (BBL), a division of Biocon Ltd.
In order to serve patients and healthcare systems around the world, Biocon Biologics, a leader in the worldwide biosimilars market, is dedicated to scientific innovation, the highest levels of quality compliance, and global scale manufacturing capabilities.
Kiran Kumar Gandhirajan, Site Head at Biocon Malaysia, commented on the development: “We are thrilled and happy to earn the ‘Bioprocessing Excellence in South Asia’ Award. It is a testament to our extensive process scientific expertise, cutting-edge production capabilities, operational excellence, and stringent quality compliance requirements. These advantages have helped us increase patient access to high-quality, reasonably-priced biosimilars and significantly impact global healthcare.
70,000 biopharma professionals took part in the survey, and Biocon Biologics was chosen as the winner since it received the most votes.
The IMAPAC-organized annual Asia-Pacific Bioprocessing Excellence Awards honor companies that exhibit great bioprocessing know-how and make use of best-in-class tools and techniques to produce bioproducts that excel in terms of efficiency, low cost, and high quality.
Biocon Biologics has created a number of technological platforms that make use of several expression systems, including mammalian cells, yeast, and bacteria.
For the production of its recombinant human insulin and insulin analog products, Biocon created the Pichia Pastoris platform technology, a proprietary technology. Similar to this, the company is able to design and produce both unique and biosimilar monoclonal antibodies for international markets because to its scalable mammalian CHO and NSO cell-based expression platforms and strong process science knowledge.
More About Bioprocessing Excellence in South Asia Award
The ‘Bioprocessing Excellence in South Asia’ Award focuses on the bioprocessing industry in South Asia, which includes countries such as India, Bangladesh, Sri Lanka, Pakistan, and Nepal. The award is presented to companies or individuals who have made significant contributions to the bioprocessing industry in the region, including but not limited to, research and development, innovation, commercialization, and sustainability.
The award is presented at the Bioprocessing Excellence Awards ceremony, which is part of the annual Biopharma Summit organized by IMAPAC. The ceremony provides a platform for industry leaders, experts, and innovators to come together and celebrate the achievements and contributions of the bioprocessing industry in South Asia.
More About IMAPAC
IMAPAC is a Singapore-based company that provides professional conference organization services, business consulting, and event management solutions. The company aims to help businesses and organizations connect with their target audience, create engaging events, and provide insightful business consulting services.
IMAPAC specializes in organizing conferences, summits, and other events in various industries such as healthcare, life sciences, finance, technology, and energy. The company works closely with industry experts, thought leaders, and academics to provide high-quality content and networking opportunities to attendees.
IMAPAC also offers business consulting services to help clients develop strategic plans, improve operations, and achieve their business goals. The company has a team of experienced consultants with expertise in various industries and functional areas.
Overall, IMAPAC is committed to delivering exceptional services that help clients achieve their objectives and create meaningful impact in their industries.
More About Biocon Biologics
Biocon Biologics has a diverse pipeline of biosimilars for the treatment of various diseases, including oncology, immunology, and diabetes. The company has a strong track record in developing and commercializing biosimilars, and has several partnerships and collaborations with global pharmaceutical companies for the development and commercialization of biosimilars.
Biocon Biologics has state-of-the-art manufacturing facilities in India, Malaysia, and Germany, which are equipped with advanced technologies and quality control systems to ensure high-quality products. The company has a strong focus on research and development, and has invested significantly in developing new and innovative biologics.
In addition to biosimilars, Biocon Biologics is also involved in the development of novel biologics and has several research programs in various stages of development. The company’s mission is to make high-quality, affordable biologics accessible to patients worldwide, and it is committed to driving innovation and excellence in the biopharmaceutical industry.
IR Research Publication is Publisher, Editorial, and Profile Building Service Provider. It Covers the Publication of Multiple Reputed Journals in the field of Biological, Medical, Pharmaceutical, and Life Sciences. IR Research Publication provides news on CDSCO decisions and FDA decisions, pharmaceutical industries, generic drugs, patents, and other pharma news.
For more details Click here
For more Pharma related updates Click here